Correlation Between BriaCell Therapeutics and Carmell Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BriaCell Therapeutics and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BriaCell Therapeutics and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BriaCell Therapeutics Corp and Carmell Therapeutics, you can compare the effects of market volatilities on BriaCell Therapeutics and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BriaCell Therapeutics with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BriaCell Therapeutics and Carmell Therapeutics.

Diversification Opportunities for BriaCell Therapeutics and Carmell Therapeutics

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between BriaCell and Carmell is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding BriaCell Therapeutics Corp and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and BriaCell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BriaCell Therapeutics Corp are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of BriaCell Therapeutics i.e., BriaCell Therapeutics and Carmell Therapeutics go up and down completely randomly.

Pair Corralation between BriaCell Therapeutics and Carmell Therapeutics

Assuming the 90 days horizon BriaCell Therapeutics Corp is expected to under-perform the Carmell Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, BriaCell Therapeutics Corp is 1.8 times less risky than Carmell Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Carmell Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  15.00  in Carmell Therapeutics on September 2, 2024 and sell it today you would lose (9.00) from holding Carmell Therapeutics or give up 60.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy31.58%
ValuesDaily Returns

BriaCell Therapeutics Corp  vs.  Carmell Therapeutics

 Performance 
       Timeline  
BriaCell Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BriaCell Therapeutics Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BriaCell Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Carmell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Insignificant
Over the last 90 days Carmell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak basic indicators, Carmell Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

BriaCell Therapeutics and Carmell Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BriaCell Therapeutics and Carmell Therapeutics

The main advantage of trading using opposite BriaCell Therapeutics and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BriaCell Therapeutics position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.
The idea behind BriaCell Therapeutics Corp and Carmell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency